Since 2012
About Ossianix
A privately held antibody discovery and engineering company developing brain-selective delivery shuttles for biotherapeutics.
The company states it has operated since 2012 and was founded by Frank Walsh, Corey Goodman and J Lynn Rutkowski. A 2012 investor press release describes the company as formed in 2011; these are different milestones.
Ossianix describes its headquarters at the University City Science Center in Philadelphia, USA, and its laboratory at Stevenage Bioscience Catalyst, UK.
Founders
Frank S Walsh
J Lynn Rutkowski
Corey Goodman
Locations, by function
Headquarters — Philadelphia, USA
University City Science Center (per the official About page; no street address published there).
Laboratory — Stevenage, UK
Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX.
Registered overseas address — Delaware, USA
Registry address of the overseas company; not an operating site.
UK registry records
Overseas company FC032376 — active (Delaware, USA).
Companies House ↗UK establishment BR017449 — open since 1 March 2012, Stevenage.
Companies House ↗OSSIANIX UK LIMITED SC443717 — a separate company, dissolved 6 July 2021. Not the current entity.
Companies House ↗
Historical collaborations
Logos appear with the dates of the announcements that mention them. No current contract is implied.
2012–2017
Investment (2012) and research collaboration announcements 2014–2017.
2012 · 2020
Investor; announcements in 2012 and 2020.
2018
Research/option agreement announced September 2018.
2022
Option and licence agreement for AT-04 with TXP1 announced November 2022.